United Therapeutics Corp UTHR
$541.89
+12.55%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 2026-09-30 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-29 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-28 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-25 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-24 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-22 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-21 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-17 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-15 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-15 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-14 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-11 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-10 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-09 | View → |
| 8-K | FORM 8-K | 2026-09-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-02 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-01 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-31 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-28 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-27 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-26 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-25 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-24 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-21 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-21 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-20 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-19 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-17 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-14 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-13 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-12 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $541.89
- Market Cap
- $23.24 billion
- 52-Week Range
- $302.19 – $609.35
- Average Volume
- 744K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.